US-based company that deals with human-centred medical device development and regulatory services ClariMed, Inc. announced on Wednesday that it is opening its new office in Leeds, UK.
This move is intended to strengthen the company's European footprint and improve its ability to serve global customers while capitalising on the region's thriving healthcare innovation ecosystem.
The company says that the Leeds office is to serve as a hub for its expanding medical device user research capabilities, providing access to a diverse pool of study participants and enriching the firm's human factors engineering insights. It is to also function as a research facility to host usability and human factors studies to support design development, market research and human factors assessments.
Kelley Kendle, ClariMed CEO, said, 'This expansion not only broadens our geographical reach but also allows us to tap into the region's rich talent pool and innovative spirit. Leeds' strategic location and thriving healthcare sector align perfectly with our mission to drive human-centred innovation in medical device development.'
Arrowhead Pharmaceuticals seeks approval for ARO-INHBE obesity study
Nicox and Glaukos sign exclusive research and licensing option agreement
Creo Medical forms strategic partnership with Micro-Tech via EUR36.7m subsidiary sale
Epitomee Medical's Capsule cleared by FDA for weight management
Eurofins strengthens biopharma testing in US with Infinity Labs acquisition